256 related articles for article (PubMed ID: 33163258)
21. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
[TBL] [Abstract][Full Text] [Related]
22. Impact of age at diagnosis on racial disparities in endometrial cancer patients.
Tarney CM; Tian C; Wang G; Dubil EA; Bateman NW; Chan JK; Elshaikh MA; Cote ML; Schildkraut JM; Shriver CD; Conrads TP; Hamilton CA; Maxwell GL; Darcy KM
Gynecol Oncol; 2018 Apr; 149(1):12-21. PubMed ID: 28800945
[TBL] [Abstract][Full Text] [Related]
23. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of high stage endometrial cancer: current perspectives.
Vitale SG; Valenti G; Gulino FA; Cignini P; Biondi A
Updates Surg; 2016 Jun; 68(2):149-54. PubMed ID: 26826083
[TBL] [Abstract][Full Text] [Related]
25. Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?
Maxwell GL; Tian C; Risinger JI; Hamilton CA; Barakat RR;
Cancer; 2008 Sep; 113(6):1431-7. PubMed ID: 18698590
[TBL] [Abstract][Full Text] [Related]
26. Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort.
Dottino JA; Zhang Q; Loose DS; Fellman B; Melendez BD; Borthwick MS; McKenzie LJ; Yuan Y; Yang RK; Broaddus RR; Lu KH; Soliman PT; Yates MS
Am J Obstet Gynecol; 2021 Mar; 224(3):278.e1-278.e14. PubMed ID: 32835719
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer racial, socioeconomic, geographic disparities: targeting the genomic landscape and splicing events in search for diagnostic, prognostic and therapeutic targets.
Marima R; Hull R; Mathabe K; Setlai B; Batra J; Sartor O; Mehrotra R; Dlamini Z
Am J Cancer Res; 2021; 11(4):1012-1030. PubMed ID: 33948343
[TBL] [Abstract][Full Text] [Related]
28. Racioethnic Disparities in Endometrial Cancer Outcomes.
Illah O; Adeeko D; Olaitan A; Gentry-Maharaj A
Diagnostics (Basel); 2024 Feb; 14(4):. PubMed ID: 38396458
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis.
Sud S; Holmes J; Eblan M; Chen R; Jones E
Gynecol Oncol; 2018 Feb; 148(2):349-356. PubMed ID: 29276059
[TBL] [Abstract][Full Text] [Related]
30. Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas.
Guttery DS; Blighe K; Polymeros K; Symonds RP; Macip S; Moss EL
Oncotarget; 2018 Mar; 9(24):17093-17103. PubMed ID: 29682207
[TBL] [Abstract][Full Text] [Related]
31. Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?
Cote ML; Ruterbusch JJ; Ahmed Q; Bandyopadhyay S; Alosh B; Abdulfatah E; Seward S; Morris R; Ali-Fehmi R
Gynecol Oncol; 2014 Apr; 133(1):38-42. PubMed ID: 24680590
[TBL] [Abstract][Full Text] [Related]
32. Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants.
Siddharth S; Sharma D
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30558195
[TBL] [Abstract][Full Text] [Related]
33. Racial disparities in survival among women with endometrial cancer in an equal access system.
Park AB; Darcy KM; Tian C; Casablanca Y; Schinkel JK; Enewold L; McGlynn KA; Shriver CD; Zhu K
Gynecol Oncol; 2021 Oct; 163(1):125-129. PubMed ID: 34325938
[TBL] [Abstract][Full Text] [Related]
34. Current and Emerging Prognostic Biomarkers in Endometrial Cancer.
Njoku K; Barr CE; Crosbie EJ
Front Oncol; 2022; 12():890908. PubMed ID: 35530346
[TBL] [Abstract][Full Text] [Related]
35. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of endometrial neoplasia.
Schottenfeld D
J Cell Biochem Suppl; 1995; 23():151-9. PubMed ID: 8747390
[TBL] [Abstract][Full Text] [Related]
37. Racial differences in tumor grade among women with endometrial cancer.
Hill HA; Coates RJ; Austin H; Correa P; Robboy SJ; Chen V; Click LA; Barrett RJ; Boyce JG; Kotz HL
Gynecol Oncol; 1995 Feb; 56(2):154-63. PubMed ID: 7896178
[TBL] [Abstract][Full Text] [Related]
38. p53 overexpression in advanced-stage endometrial adenocarcinoma.
Kohler MF; Carney P; Dodge R; Soper JT; Clarke-Pearson DL; Marks JR; Berchuck A
Am J Obstet Gynecol; 1996 Nov; 175(5):1246-52. PubMed ID: 8942496
[TBL] [Abstract][Full Text] [Related]
39. Racial differences in endometrial cancer survival: the black/white cancer survival study.
Hill HA; Eley JW; Harlan LC; Greenberg RS; Barrett RJ; Chen VW
Obstet Gynecol; 1996 Dec; 88(6):919-26. PubMed ID: 8942828
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
